Corruption of the intra-gene DNA methylation architecture is a hallmark of cancer.

Epigenetic processes--including DNA methylation--are increasingly seen as having a fundamental role in chronic diseases like cancer. It is well known that methylation levels at particular genes or loci differ between normal and diseased tissue. Here we investigate whether the intra-gene methylation...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Thomas E Bartlett, Alexey Zaikin, Sofia C Olhede, James West, Andrew E Teschendorff, Martin Widschwendter
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
R
Q
Acceso en línea:https://doaj.org/article/6cd3b9f19a8540cd8d21a45df7454836
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6cd3b9f19a8540cd8d21a45df7454836
record_format dspace
spelling oai:doaj.org-article:6cd3b9f19a8540cd8d21a45df74548362021-11-18T07:37:35ZCorruption of the intra-gene DNA methylation architecture is a hallmark of cancer.1932-620310.1371/journal.pone.0068285https://doaj.org/article/6cd3b9f19a8540cd8d21a45df74548362013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23874574/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203Epigenetic processes--including DNA methylation--are increasingly seen as having a fundamental role in chronic diseases like cancer. It is well known that methylation levels at particular genes or loci differ between normal and diseased tissue. Here we investigate whether the intra-gene methylation architecture is corrupted in cancer and whether the variability of levels of methylation of individual CpGs within a defined gene is able to discriminate cancerous from normal tissue, and is associated with heterogeneous tumour phenotype, as defined by gene expression. We analysed 270985 CpGs annotated to 18272 genes, in 3284 cancerous and 681 normal samples, corresponding to 14 different cancer types. In doing so, we found novel differences in intra-gene methylation pattern across phenotypes, particularly in those genes which are crucial for stem cell biology; our measures of intra-gene methylation architecture are a better determinant of phenotype than measures based on mean methylation level alone (K-S test [Formula: see text] in all 14 diseases tested). These per-gene methylation measures also represent a considerable reduction in complexity, compared to conventional per-CpG beta-values. Our findings strongly support the view that intra-gene methylation architecture has great clinical potential for the development of DNA-based cancer biomarkers.Thomas E BartlettAlexey ZaikinSofia C OlhedeJames WestAndrew E TeschendorffMartin WidschwendterPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 7, p e68285 (2013)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Thomas E Bartlett
Alexey Zaikin
Sofia C Olhede
James West
Andrew E Teschendorff
Martin Widschwendter
Corruption of the intra-gene DNA methylation architecture is a hallmark of cancer.
description Epigenetic processes--including DNA methylation--are increasingly seen as having a fundamental role in chronic diseases like cancer. It is well known that methylation levels at particular genes or loci differ between normal and diseased tissue. Here we investigate whether the intra-gene methylation architecture is corrupted in cancer and whether the variability of levels of methylation of individual CpGs within a defined gene is able to discriminate cancerous from normal tissue, and is associated with heterogeneous tumour phenotype, as defined by gene expression. We analysed 270985 CpGs annotated to 18272 genes, in 3284 cancerous and 681 normal samples, corresponding to 14 different cancer types. In doing so, we found novel differences in intra-gene methylation pattern across phenotypes, particularly in those genes which are crucial for stem cell biology; our measures of intra-gene methylation architecture are a better determinant of phenotype than measures based on mean methylation level alone (K-S test [Formula: see text] in all 14 diseases tested). These per-gene methylation measures also represent a considerable reduction in complexity, compared to conventional per-CpG beta-values. Our findings strongly support the view that intra-gene methylation architecture has great clinical potential for the development of DNA-based cancer biomarkers.
format article
author Thomas E Bartlett
Alexey Zaikin
Sofia C Olhede
James West
Andrew E Teschendorff
Martin Widschwendter
author_facet Thomas E Bartlett
Alexey Zaikin
Sofia C Olhede
James West
Andrew E Teschendorff
Martin Widschwendter
author_sort Thomas E Bartlett
title Corruption of the intra-gene DNA methylation architecture is a hallmark of cancer.
title_short Corruption of the intra-gene DNA methylation architecture is a hallmark of cancer.
title_full Corruption of the intra-gene DNA methylation architecture is a hallmark of cancer.
title_fullStr Corruption of the intra-gene DNA methylation architecture is a hallmark of cancer.
title_full_unstemmed Corruption of the intra-gene DNA methylation architecture is a hallmark of cancer.
title_sort corruption of the intra-gene dna methylation architecture is a hallmark of cancer.
publisher Public Library of Science (PLoS)
publishDate 2013
url https://doaj.org/article/6cd3b9f19a8540cd8d21a45df7454836
work_keys_str_mv AT thomasebartlett corruptionoftheintragenednamethylationarchitectureisahallmarkofcancer
AT alexeyzaikin corruptionoftheintragenednamethylationarchitectureisahallmarkofcancer
AT sofiacolhede corruptionoftheintragenednamethylationarchitectureisahallmarkofcancer
AT jameswest corruptionoftheintragenednamethylationarchitectureisahallmarkofcancer
AT andreweteschendorff corruptionoftheintragenednamethylationarchitectureisahallmarkofcancer
AT martinwidschwendter corruptionoftheintragenednamethylationarchitectureisahallmarkofcancer
_version_ 1718423166581211136